Startups

Ventureport Hosts Soft Launch of InvestHK’s Fast-Track Connect

Six technology companies showcased solutions for financial research, wealth management, consumer insight and security to investors and institutions.

Updated

November 14, 2026 11:54 PM

Arnold Lau and King Leung (back row, fourth and fifth from left), Associate Directors-General of Investment Promotion at InvestHK, join the Ventureport team and representatives from the six technology companies. PHOTO: VENTUREPORT

Ventureport hosted the soft launch of InvestHK’s Fast-Track Connect at its AI+ Tech+ Finance+ gathering on 30 October, bringing more than 100 guests to Pier 1929 in Wan Chai.

Sponsored by InvestHK, the event brought investors, institutional representatives and technology companies together to explore investment and business partnerships. Six companies took the stage to showcase software solutions for financial professionals, consumer research, local AI computing and digital asset security.

‍

King Leung, Associate Director-General of Investment Promotion at InvestHK, delivers opening remarks. PHOTO: VENTUREPORT

‍

Connecting companies with investors and institutions

The Acting Head of Startups, at InvestHK, Chin-yung (CY), and the Senior Vice President (Fintech), Pauline Fan, introduced Fast-Track Connect.  They explained how the agency’s international network connects it with technology companies seeking investment, customers and business opportunities in Hong Kong.

‍

Chin-yung (CY) Lu (left) and Pauline Fan (right) introduce InvestHK’s Fast-Track Connect. PHOTO: VENTUREPORT

‍

Their remarks also highlight the need for a more structured approach to build these connections. Investors need easier ways to identify companies that match their interests, while institutions seeking new technology need access to businesses whose products could support their operations or benefit their customers.  

To address this need, Fast-Track Connect provides an online platform where technology companies can publish profiles outlining their products and funding needs. Investors and corporate participants can identify relevant businesses and contact them to explore potential investments or collaborations. Service providers and community partners are also part of the platform. Alongside investors and corporate participants, these groups are designated as Champions on the platform.

Curated by InvestHK and supported by the Financial Services and the Treasury Bureau, Fast-Track Connect builds on the Global Fast Track Programme. It aims to help local enterprises expand into Chinese Mainland, Southeast Asia and other markets.

‍

Guests at Ventureport’s AI+ Tech+ Finance+ gathering. PHOTO: VENTUREPORT

‍

Financial research and client advice

AlphaPai, an AI-powered investment research platform developed by financial technology company RabyteTech, presented tools for financial research, including gathering data, monitoring financial instruments and comparing information from corporate earnings calls.

‍

AlphaPai presents its AI investment research platform. PHOTO: VENTUREPORT

‍

At the event, the team explained how users can give research instructions in everyday language, while the software retrieves and processes information to prepare reports and presentation materials. Examples included tracking market developments and comparing company statements over time. The team also emphasised the importance of traceable sources, allowing analysts to verify the information behind their research.

A2B2.AI, a fintech startup, presented AI- powered tools designed to support investors and wealth advisers. Its specialist AI agents—software designed to carry out particular tasks—help prepare client meeting briefings, monitor financial products approaching maturity and identify market developments relevant to individual clients, according to the team.

‍

A2B2.AI co-founder Teresa Goh presents tools for investors and wealth advisers. PHOTO: VENTUREPORT

‍

For investors, the tool can help make sense of lengthy documents provided by advisers and bring information from different accounts together to assess risk exposure. For wealth professionals, the tools support preparation and follow-up around client meetings.

The team described its approach as combining AI with human expertise to support financial decision- making. It also clarified that the platform does not execute investment transactions on behalf of clients, leaving those decisions and actions in their hands.  

‍

Consumer insight and local AI

Preferences AI, an AI startup specialising in synthetic consumer research, presented simulated consumer profiles that businesses can use to explore how different audiences might respond to products, pricing and marketing messages. These profiles generate modelled responses rather than feedback from people directly interviewed or surveyed.

‍

Preferences AI co-founder Tamir Abdel-wahab discusses AI for consumer research. PHOTO: VENTUREPORT

‍

The company described that its profiles are grounded in population data and account for differences between local audiences Businesses can use them to explore pricing or packaging options, as well as ask follow-up questions to understand the reasons behind a particular response. The team also discussed testing its models and working with academics to help validate the approach. It said the technology could help businesses explore consumer preferences more quickly.  

ByteFuture, an AI infrastructure startup, focused on running AI on users’ own hardware. It introduced Olares, its operating system, and Olares One, a device designed to run AI models and applications locally.

‍

ByteFuture co-founder Shayla presents Olares, a system for running AI locally to keep data private. PHOTO: VENTUREPORT

‍

Its applications included personal assistance, financial research and content creation. The team argued that users handling private documents or proprietary trading strategies may prefer to retain that material on equipment they control.

A demonstration of AI-generated video illustrated creative work the team said could run locally. It also described applications and agents available through its software marketplace.

‍

Digital assets and agent security

PureGlobal, a fintech company, addressed digital asset custody: the systems used to safeguard access to digital assets. Its team described technology for protecting access credentials and supporting offline transactions without a conventional internet connection.

‍

Chief Business Officer of PureGlobal, Larry Lundy, discusses digital asset security. PHOTO: VENTUREPORT

‍

The presentation focused on infrastructure for institutions holding and transferring digital assets, including security under different operating conditions.

SlowMist, a blockchain security firm, examined the risks of giving AI agents permission to read information and perform tasks. Its examples included malicious instructions concealed in material an agent might encounter and attacks exploiting access granted to software.

‍

Tony Tan, HK Community Lead of SlowMist, discusses AI agent security. PHOTO: VENTUREPORT

‍

The team discussed security auditing, monitoring and investigations alongside risks arising from third-party tools and an agent’s stored information. One scenario involved exposing a wallet’s recovery phrase, which can give someone control over its assets.

Keep Reading

Artificial Intelligence

DeepCyte Raises US$1.5M to Use AI and Single-Cell Analysis to Predict Drug Toxicity

A new approach examines how individual cells respond to drugs, aiming to identify risks earlier in development.

Updated

August 10, 2026 5:56 PM

Close up of a capsule blister pack. PHOTO: UNSPLASH

DeepCyte, a startup in the drug development space, is focusing on a long-standing problem: why drugs that appear safe in early testing still fail in clinical trials or are withdrawn later due to toxicity. DeepCyte has launched with US$1.5 million in seed funding to build tools that detect and explain the harmful effects of drugs at much earlier stages.

The startup’s approach focuses on how individual cells respond to a drug. Instead of analysing cells in bulk, it studies them one by one. This helps capture differences in how cells react, which are often missed in traditional testing methods.

Drug toxicity remains one of the main reasons for failure in drug development. Methods such as animal testing and bulk cell analysis do not always reflect how human cells behave. This gap has pushed the industry to look for more reliable and human-relevant ways to test drug safety.

DeepCyte combines cell-level data with artificial intelligence. Its platform, MetaCore, studies what is happening inside individual cells by capturing detailed molecular information. This data is used to build large datasets that can train AI models.

Additionally, the company has developed an AI system called DeeImmuno. It is designed to predict whether a drug could be toxic and identify the biological reasons behind it. In internal testing on 100 drugs, the system identified different types of toxicity and their underlying mechanisms with a reported accuracy of 94 percent.

The focus on explaining why a drug is toxic, not just whether it is, reflects a broader shift in the industry. Regulators such as the U.S. Food and Drug Administration and the European Medicines Agency have been encouraging methods that rely more on human cell data and clearer biological evidence. The seed funding will be used to develop and scale these tools. The company aims to help drug developers make earlier decisions, which could reduce costly failures in later stages. Whether tools like this become widely used will depend on how they perform in real-world settings. For now, DeepCyte’s approach highlights a growing effort to make drug testing more precise by focusing on how drugs affect cells at the most detailed level.